The impact of corticosteroid treatment on hemoglobin A1C levels among patients with type-2 diabetes with chronic obstructive pulmonary disease exacerbation

Respiratory Medicine

Volumn 108, Issue 11, 2014, Pages 1641-1646

  Habib, George ^a,b   Dar Esaif, Yusri ^b   Bishara, Hashim ^b   Artul, Suheil ^b   Badarny, Samih ^a   Chernin, Mark ^a   Jabbour, Adel ^b  

^a CARMEL MEDICAL CENTER   (Israel)

^b Nazareth Hospital   (Israel)

Author keywords

A1c; Chronic obstructive pulmonary disease exacerbation; Corticosteroids Diabetes; Hemoglobin

Indexed keywords

CORTICOSTEROID; GLUCOSE; HEMOGLOBIN A1C; HYDROCORTISONE; PREDNISONE; GLUCOCORTICOID; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIABETIC PATIENT; DISEASE DURATION; DISEASE EXACERBATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; VERY ELDERLY; BLOOD; CASE CONTROL STUDY; COMPLICATION; DRUG EFFECTS; HOSPITALIZATION; METABOLISM; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOCORTICOIDS; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84922419346     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.08.006     Document Type: Article

References (18)

1. D.E. Niewoehner The role of systemic corticosteroids in acute exacerbation of chronic obstructive pulmonary disease Am J Respir Med 1 2002 243 248
2. D.D. Sin, and S.F. Man Corticosteroids and adrenoreceptor agonists: the compliments of combination therapy in chronic airways diseases Eur J Pharmacol 533 2006 28 35
3. J.A. Walters, W. Wang, C. Morely, A. Soltani, and R. Wood-Baker Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease Cochrane Database Sys Rev 10 2011 CD006798
4. P. Genolet, C. Petite, and P.A. Petignat Steroid-induced hyperglycemia, a common medical problem in medicine, without evidence-based guidelines Rev Med Swisse 8 2012 800-2, 804-805
5. G.F. Davis Adverse effects of corticosteroids: II Syst Clin Dermatol 4 1986 161 169
6. D.H. Jensen, K. Aaboe, and J.E. Henriksen Steroid induced insulin resistance and impaired glucose tolerance are both associated with progressive decline of incretin effect in first-degree relative of patients with type-2 diabetes Diabetologia 55 2012 1406 1416
7. S.C. Kalhan, and P.A. Adam Inhibitory effect of prednisone on insulin secretion in man: model for duplication of blood glucose concentration J Clin Endocrinol Metab 41 1975 600 610
8. J.E. Henriksen, F. Alford, G.M. Ward, and H. Beck-Nielsen Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients Diabetologia 40 1997 1439 1448
9. A. Perez, S. Jansen-Chaparro, and I. Saigi Glucocorticoid-induced hyperglycemia J Diabetes 6 2014 9 20 10.1111/1753-0407.12090
10. S. Ito, H. Quishima, Y. Kondo, M. Sugihara, T. Hayashi, Y. Chino, D. Goto, I. Matsumoto, and T. Sumida Early diagnosis and treatment of steroid-induced diabetes mellitus in patients with rheumatoid arthritis and other connective tissue disease Mod Rheumatol 24 2014 529
11. A. Khanna, A.L. Bush, J.M. Swint, M.F. Peskin, R.L. Street Jr.; and A.D. Naik Hemoglobin A1C improvements and better diabetes-specific quality of life among participants completing diabetes self-management programs: a nested cohort study Health Qual Life Outcomes 10 2012 48 10.1186/1477-7525-10-48
12. J. Vestbo, S.S. Hurd, and A.G. Agusti Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 187 2013 347 365
13. M.G. Burt, G.W. Roberts, N.R. Aguilar-Rosa, P. Frith, and S.N. Stranks Continuous monitoring of circadian patterns in patients receiving prednisolone for COPD J Clin Endocrinol Metab 96 2011 1789 1796
14. S.H. Kim, F. Abbasi, and G.M. Reaven Impact of degree of obesity on surrogate estimate of insulin resistance Diabetes Care 8 2004 1998 2002
15. M.G. Gohel, and A.N. Chacko Serum GGT activity and hcCRP levels in patients with type 2 diabetes mellitus with good and poor glycemic control: an evidence linking oxidative stress, inflammation and glycemic control J Diab Metab Disord 12 2013 56 61
16. F. Aksu, N. Capan, R. Ofluoglu, S. Cnbacan, B. Yavuz, and K.O. Akin C-reactive prorein levels are raised in chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure J Thorac Dis 5 2013 414 421
17. S.Y. Kim, C.G. Yoo, and C.T. Lee Incidence and risk factors of steroid-induced diabetes in patients with respiratory disease J Korean Med Sci 26 2011 264 267
18. K. Okita, H. Iwahashi, J. Kozawa, Y. Okauchi, T. Funahashi, A. Imagawa, and I. Shimomura Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy Endocr J 60 2013 283 290